Evidence map›Paper›PMID 38825684›Full record

ArticleEcho research and practice2024

Evaluation of left ventricular filling pressure by echocardiography in patients with atrial fibrillation.

Faraz H Khan, Debbie Zhao, Jong-Won Ha, Sherif F Nagueh, Jens-Uwe Voigt, Allan L Klein, Einar Gude, Kaspar Broch, Nicholas Chan, Gina M Quill and 18 more

Registry-linked trialAbstract read
In one paragraph

Article in Echo research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07436299 (Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07436299 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation: A Prospective Multicenter Study

TypeobservationalSponsorOslo University HospitalRan2026 to 2029Enrolled400ConditionsHeart Failure (HF), Atrial Fibrillation (AF)
3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Left ventricular diastolic dysfunction in non-myocardial disorders.European heart journal. Cardiovascular Imaging · 2024
    Review
  9. Left Ventricular Diastolic Dysfunction in the Critically Ill: The Rubik's Cube of Echocardiography.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Faraz H Khan *Institute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway.
Debbie Zhao *Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Jong-Won HaCardiology Division, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Sherif F NaguehMethodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Jens-Uwe VoigtDepartment of Cardiovascular Diseases, Department of Cardiovascular Sciences, University Hospitals Leuven, Catholic University of Leuven, Leuven, Belgium.
Allan L KleinCleveland Clinic, Cleveland, OH, USA.
Einar GudeInstitute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway.
Kaspar BrochInstitute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway.
Nicholas ChanCleveland Clinic, Cleveland, OH, USA.
Gina M QuillAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Robert N DoughtyDepartment of Medicine, University of Auckland, Auckland, New Zealand.
Alistair YoungAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Ji-Won SeoCardiology Division, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Eusebio García-IzquierdoCardiology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Vanessa Moñivas-PalomeroCardiology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Susana Mingo-SantosCardiology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Tom Kai Ming WangCleveland Clinic, Cleveland, OH, USA.
Stephanie BezyDepartment of Cardiovascular Diseases, Department of Cardiovascular Sciences, University Hospitals Leuven, Catholic University of Leuven, Leuven, Belgium.
Nobuyuki OhteDepartment of cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Helge SkulstadInstitute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway.
Carmen C BeladanUniversity of Medicine and Pharmacy "Carol Davila", Emergency Institute for, Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Sos. Fundeni 258, sector 2, Euroecolab, Bucharest, 0223228, Romania.
Bogdan A PopescuUniversity of Medicine and Pharmacy "Carol Davila", Emergency Institute for, Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Sos. Fundeni 258, sector 2, Euroecolab, Bucharest, 0223228, Romania.
Shohei KikuchiDepartment of cardiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Vasileios PanisDepartment of Cardiology, CHU Rennes and Inserm, LTSI, University of Rennes, Rennes, France.
Erwan DonalDepartment of Cardiology, CHU Rennes and Inserm, LTSI, University of Rennes, Rennes, France.
Espen W RemmeInstitute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway.
Martyn P NashAuckland Bioengineering Institute, University of Auckland, Auckland, New Zealand.
Otto A SmisethInstitute for Surgical Research, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, University of Oslo, Rikshospitalet, Oslo, N-0027, Norway. otto.smiseth@gmail.com.

Funding

Health Research Council of New Zealand 17/608 23/527Helse Sør-Øst RHF 2018018Pūtahi Manawa / Healthy Hearts for Aotearoa New Zealand Centre of Research Excellence Research Fellowship FLW23-001Research Foundation Flanders 1832922NResearch Foundation Flanders G092318N
6 · The paper itself

Abstract

backgroundEchocardiography is widely used to evaluate left ventricular (LV) diastolic function in patients suspected of heart failure. For patients in sinus rhythm, a combination of several echocardiographic parameters can differentiate between normal and elevated LV filling pressure with good accuracy. However, there is no established echocardiographic approach for the evaluation of LV filling pressure in patients with atrial fibrillation. The objective of the present study was to determine if a combination of several echocardiographic and clinical parameters may be used to evaluate LV filling pressure in patients with atrial fibrillation.

resultsIn a multicentre study of 148 atrial fibrillation patients, several echocardiographic parameters were tested against invasively measured LV filling pressure as the reference method. No single parameter had sufficiently strong association with LV filling pressure to be recommended for clinical use. Based on univariate regression analysis in the present study, and evidence from existing literature, we developed a two-step algorithm for differentiation between normal and elevated LV filling pressure, defining values ≥ 15 mmHg as elevated. The parameters in the first step included the ratio between mitral early flow velocity and septal mitral annular velocity (septal E/e'), mitral E velocity, deceleration time of E, and peak tricuspid regurgitation velocity. Patients who could not be classified in the first step were tested in a second step by applying supplementary parameters, which included left atrial reservoir strain, pulmonary venous systolic/diastolic velocity ratio, and body mass index. This two-step algorithm classified patients as having either normal or elevated LV filling pressure with 75% accuracy and with 85% feasibility. Accuracy in EF ≥ 50% and EF < 50% was similar (75% and 76%).

conclusionsIn patients with atrial fibrillation, no single echocardiographic parameter was sufficiently reliable to be used clinically to identify elevated LV filling pressure. An algorithm that combined several echocardiographic parameters and body mass index, however, was able to classify patients as having normal or elevated LV filling pressure with moderate accuracy and high feasibility.

Indexed as

Atrial fibrillationDiastolic functionEchocardiographyFilling pressureLeft atriumLeft ventricle

Identifiers

PMID38825684
PMCPMC11145766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.